Voloridge Investment Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-46,070
| Closed | -$441K | – | 1415 |
|
|
2022
Q3 | $441K | Sell |
46,070
-90,758
| -66% | -$869K | ﹤0.01% | 1283 |
|
|
2022
Q2 | $1.11M | Sell |
136,828
-76,009
| -36% | -$615K | 0.01% | 1159 |
|
|
2022
Q1 | $3.6M | Buy |
212,837
+46,775
| +28% | +$791K | 0.02% | 754 |
|
|
2021
Q4 | $3.57M | Buy |
+166,062
| New | +$3.57M | 0.02% | 844 |
|
|
2021
Q3 | – | Sell |
-59,891
| Closed | -$3.28M | – | 1621 |
|
|
2021
Q2 | $3.28M | Buy |
59,891
+52,109
| +670% | +$2.85M | 0.02% | 797 |
|
|
2021
Q1 | $574K | Buy |
+7,782
| New | +$574K | ﹤0.01% | 1154 |
|